Tap to Read ➤

5 Pharma Stocks Recommended By Motilal Oswal For More Than 30% Gains

These 5 Pharma Stocks are given a 'buy' rating by the brokerage in Valuation Snapshot published on 17 June 2022.
Solara Active Pharma Sciences Ltd
The CMP of the stock is Rs 350.45 on NSE, the brokerage has given a target price of Rs 740. It has the potential to gain nearly 111.16%.
Laurus Labs
The CMP of the stock is Rs 468.25 on NSE, the brokerage has given a target price of Rs 700. It has the potential to gain nearly 49.49%.
Gland Pharmaceuticals Ltd
The CMP of the stock is Rs 2567.15 on NSE, the brokerage has given a target price of Rs 3700. It has the potential to gain nearly 44.13%.
ERIS Lifescience Ltd
The CMP of the stock is Rs 621.70 on NSE, the brokerage has given a target price of Rs 870. It has the potential to gain nearly 39.94%.
Apollo Hospital Enterprises Ltd
The CMP of the stock is Rs 3701.25 on NSE, the brokerage has given a target price of Rs 4900. It has the potential to gain nearly 32.39%.
Thank you for reading. Follow Goodreturns.in.
Swipe up to know more!
Add Button Text